{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:28Z","timestamp":1790612188513,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12370692"],"award-info":[{"award-number":["GR-2019-12370692"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: the reference method for detection of myositis-specific and myositis-associated antibodies (MSAs and MAAs) is considered immunoprecipitation (IP), but it is routinely replaced by semi-automated methods, like lineblot (LB). Few data are available on the consistency with clinical diagnoses; thus, we aim at analysing these aspects. Methods: sixty-nine patients with idiopathic inflammatory myopathies (IIM) were studied via LB (Myositis Antigens Profile 3 EUROLINE, Euroimmun) and IP (RNA and protein antigens). The degree of concordance between methods was calculated using Cohen\u2019s coefficient. Results: a substantial concordance was found for anti-Ku and anti-PM\/Scl and a moderate concordance was found for anti-Jo1 and anti\u2013Mi-2, while a fair concordance was found for anti-EJ, anti-SRP, and anti-Ro52 antibodies. The concordance could not be calculated for anti-OJ, anti-PL-7, anti-PL-12, anti-NXP2, anti-TIF1\u0263, and anti-MDA5, because they were only detected with one method. Multiple MSAs were found only with LB in 2\/69 sera. Anti-MDA5, TIF1\u0263, NXP2 (detected via IP), and anti-Jo1 in anti-synthetase syndrome (both LB and IP) had the best concordance with clinical diagnosis. Conclusions: LB and IP show substantial concordance for PM\/Scl and Ku, and moderate concordance for Jo1 and Mi-2, with a good concordance with clinical diagnoses. IP shows a high performance for DM-associated MSAs. LB seems to be more sensitive in detecting anti-Ro52 antibodies, but it identified multiple MSAs, unlike IP.<\/jats:p>","DOI":"10.3390\/diagnostics14192192","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T12:06:32Z","timestamp":1727697992000},"page":"2192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-2979","authenticated-orcid":false,"given":"Fabrizio","family":"Angeli","sequence":"first","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy"},{"name":"Clinical and Experimental Science Department, University of Brescia, Piazzale Spedali Civili 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5296-0416","authenticated-orcid":false,"given":"Eleonora","family":"Pedretti","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy"},{"name":"Clinical and Experimental Science Department, University of Brescia, Piazzale Spedali Civili 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emirena","family":"Garrafa","sequence":"additional","affiliation":[{"name":"Central Laboratory Unit, ASST Spedali Civili, Molecular and Transitional Medicine, University of Brescia, Piazzale Spedali Civili 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-4936","authenticated-orcid":false,"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy"},{"name":"Clinical and Experimental Science Department, University of Brescia, Piazzale Spedali Civili 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology IRCCS, Humanitas Research Hospital, via Manzoni 56, Rozzano,20089 Milano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-6124","authenticated-orcid":false,"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy"},{"name":"Clinical and Experimental Science Department, University of Brescia, Piazzale Spedali Civili 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11926-014-0464-1","article-title":"Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies","volume":"16","author":"Tansley","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/annrheumdis-2018-214690","article-title":"Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies","volume":"78","author":"Holmqvist","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","article-title":"Antisynthetase syndrome","volume":"70","author":"Hamidou","year":"2003","journal-title":"Jt. Bone Spine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1329197","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2012","journal-title":"Semin. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.100316","article-title":"Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma","volume":"37","author":"Ceribelli","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","first-page":"277","article-title":"Agreement between local and central anti-synthetase antibodies detection: Results from the Classification Criteria of Anti-Synthetase Syndrome project biobank","volume":"42","author":"Loganathan","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102680","DOI":"10.1016\/j.jaut.2021.102680","article-title":"Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera","volume":"122","author":"Muro","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","article-title":"Anti-OJ autoantibodies: Rare or underdetected?","volume":"18","author":"Vulsteke","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ghirardello, A., Gatto, M., Franco, C., Zanatta, E., Padoan, R., Ienna, L., Gallo, N., Zen, M., Lundberg, I.E., and Mahler, M. (2023). Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies. Diagnostics, 13.","DOI":"10.3390\/diagnostics13193080"},{"key":"ref_24","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: Clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-021-08920-y","article-title":"An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations","volume":"63","author":"Fredi","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mahler, M., Betteridge, Z., Bentow, C., Richards, M., Seaman, A., Chinoy, H., and McHugh, N. (2019). Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00848"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sato, S., Murakami, A., Kuwajima, A., Takehara, K., Mimori, T., Kawakami, A., Mishima, M., Suda, T., Seishima, M., and Fujimoto, M. (2016). Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154285"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nombel, A., Pin, J.J., Fabien, N., Miossec, P., and Coutant, F. (2022). Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112969"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.semarthrit.2021.03.012","article-title":"Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review","volume":"51","author":"Vulsteke","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1136\/annrheumdis-2019-215884","article-title":"Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: A better performance?","volume":"79","author":"Cavazzana","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00296-023-05279-5","article-title":"Myositis autoantibodies detected by line blot immunoassay: Clinical associations and correlation with antibody signal intensity","volume":"43","author":"Rita","year":"2023","journal-title":"Rheumatol. Int."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:08:06Z","timestamp":1760112486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":34,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["diagnostics14192192"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14192192","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}